TY - CHAP M1 - Book, Section TI - Medications Affecting Cardiac and Renal Function A1 - Pelletier-Dattu, Catherine E. PY - 2017 T2 - Lange Smart Charts: Pharmacology, 2e AB - Table Graphic Jump Location|Download (.pdf)|PrintAcanthosis NigricansWarty growths and hyperpigmentation characteristically found in the axilla and groin; associated with certain drugs, endocrine disorders, obesity, or malignancy.AlopeciaAbsence or loss of hair.AnginaChest discomfort caused by insufficient cardiac blood flow resulting in cardiac ischemia.Conn's SyndromePrimary hyperaldosteronism.Hypertensive EmergnecyHypertensive urgency with end-organ damage.Hypertensive UrgencySeverely elevated BP (systolic >220 or diastolic >120) with no evidence of end-organ damage.HypertrichosisExcessive hair growth.Lupus-Like SyndromeDrug-induced syndrome resembling the symptoms associated with SLE; rarely demonstrates nephritic component.PheochromocytomaCatecholamine-secreting tumor of the adrenal gland.Quinidine SyncopeRecurrent light-headedness and fainting associated with use of quinidine.Reye's SyndromeA rare syndrome of encephalitis and hepatic dysfunction seen in children recovering from a viral illness linked to aspirin.RhabdomyolysisDestruction of skeletal muscle cells.Thrombotic Thrombocytopenic PurpuraCoagulopathy seen in adults; associated with central nervous system involvement.TinnitisRinging in the ears.ToleranceRepeated administration of medication leads to decreased effectiveness.Torsade de PointesA ventricular arrhythmia often induced by antiarrhythmic drugs (especially those that prolong the QT interval). Its morphology is that of a polymorphic ventricular tachycardia often with an increasing then decreasing QRS amplitude.Wolff-Parkinson-White SyndromeSyndrome associated with ventricular arrhythmias due to the presence of an accessory conduction pathway between the SA and AV nodes. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/04/20 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1114498594 ER -